South Africa's launch of Lenacapavir marks a transformative moment in the fight against HIV, promising to significantly reduce new infections and improve health outcomes for millions.

Limited supplies threaten potential positive effect of HIV prevention drug lenacapavir

Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa